Compare Cardinal Health Inc (CAH) vs iShares MSCI Taiwan ETF (EWT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cardinal Health Inc vs iShares MSCI Taiwan ETF — how do they compare? Cardinal Health Inc trades at $229.05 (market cap $53.89B), while iShares MSCI Taiwan ETF trades at $101.6. The key difference: Cardinal Health Inc pays a 0.89% dividend while iShares MSCI Taiwan ETF pays none. Which is the better fit depends on your goals.
| CAH | EWT | |
|---|---|---|
Market Cap | $53.89B | — |
Sector | Health | Broad Market / Factor |
52-Week High | $239.71 | $111.53 |
52-Week Low | $146.04 | $58.05 |
Enterprise Value | $58.87B | — |
Dividend Yield | 0.89% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cardinal Health (CAH) trades at $233.66, down 0.91% in the last session, with a bullish technical signal from moving averages and strong analyst support. The company has consistently beaten earnings estimates in recent quarters, with Q1 2026 EPS of $3.17 surpassing expectations. Revenue reached $222.58 billion in 2025, though net margins remain thin at 0.62%. Recent news highlights growth potential in medical supplies, with earnings results for fiscal 2026 due August 11.
The outlook for CAH is positive, driven by earnings momentum and sector tailwinds, but risks include high leverage with debt-to-asset ratio at 16.09% and competitive pressures. Analyst consensus is bullish with a $248 price target, suggesting 6% upside. Investors should weigh solid operational cash flow against negative shareholder equity and investing outflows.
EWT, the iShares MSCI Taiwan ETF, trades at $101.88, down 4.04% on the day amid a bearish technical signal. The ETF has delivered strong returns in 2026, more than doubling from its 2025 close, driven by Taiwan's critical role in the global semiconductor and AI supply chain. However, key financial ratios are unavailable, and the technical outlook is mixed, with moving averages bullish but oscillators neutral.
The outlook for EWT is clouded by geopolitical tensions with China and potential currency volatility, though its exposure to the AI-driven semiconductor boom offers significant growth potential. Investors face a trade-off between high-reward tech exposure and substantial geopolitical risk, with the current price near key support levels suggesting a cautious near-term stance is warranted.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cardinal Health Inc
Cardinal Health is a leading pharmaceutical wholesaler, engaged in the sourcing and distribution of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail-order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and McKesson, the three compose well over 90% of the U.S. pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
Read more on CAH →About iShares MSCI Taiwan ETF
EWT tracks the MSCI Taiwan 25/50 Index, providing targeted exposure to large and mid-cap companies in Taiwan. It is heavily concentrated in the information technology sector, serving as a liquid instrument for investors seeking a single-country view of Taiwan's export-oriented and tech-driven economy.
Read more on EWT →
